Introduction {#S1}
============

The organization of cells into multiple membranous compartments with specific biochemical functions requires complex intracellular traffic and sorting of lipids and proteins, to transport them from their sites of synthesis to their functional destination. Intracellular transport involves lipid vesicles or tubules with the capacity to fuse with one another or to be secreted. They collectively participate in the dynamic exchanges necessary for cell homeostasis ([@B114]; [@B123]). Membrane traffic is tightly coordinated with protein synthesis, signal transduction of environmental stimuli and cytoskeleton organization, allowing the implementation of key cellular functions such as endocytosis, exocytosis, or migration ([@B86]; [@B48]; [@B142]; [@B80]; [@B82]; [@B136]; [@B12]; [@B125]).

Several families of molecular components required for orchestrating membrane vesicle exchange and transport during this process are conserved. They include adaptor and coat proteins, small GTP-binding proteins (GTPases), as well as Synaptosome Associated Protein (SNAP) Receptor (SNARE) proteins and SNARE binding proteins ([@B60]). The vast superfamily of GTPases is involved in the establishment or regulation of virtually every step of intracellular membrane trafficking. They behave as molecular switches that can alternate between active and inactive states, through GTP binding and hydrolysis into GDP ([@B133]; [@B127]). The largest group of GTPases involved in intracellular membrane traffic is the Rab proteins family ([@B71]). Rab GTPases specifically localize to different intracellular compartments, regulating vesicle formation and sorting, as well as transport along the cytoskeletal network. Each Rab protein can be recruited to specific membrane subdomains of a defined organelle and is associated to multiple effectors controlling membrane fusion and trafficking. Rab interaction with the membrane fusion complexes and cytoskeleton regulators is therefore crucial for cellular functions, including endocytosis and autophagy ([@B19]; [@B11]; [@B42]; [@B139]; [@B159]).

Here, we review the literature concerning a less-well known family of proteins involved in the complex biochemical crosstalk established between the cytoskeleton and intracellular vesicles. This small group of proteins was named RUFY for "[RU]{.ul}N and [FY]{.ul}VE domain-containing." RUFYs share a common structural domain organization, including an N-terminal RUN domain, one or several coiled-coil (CC) repeats and a C-terminal FYVE domain ([Figure 1A](#F1){ref-type="fig"}). The molecular structures of the different RUFY proteins has been described ([@B31]; [@B83]; [@B66]; [@B64]), but their function in endocytic regulation and their physiological relevance at the organismal level are still poorly characterized ([@B64]; [@B137]). We revisit here how the *rufy* gene family was annotated, and propose the addition of a novel member, the *fyco1* (FYVE and Coiled-coil containing domain 1) gene given its sequence and functional similarities with the other *rufy* genes ([@B102]; [@B138]). We also highlight recent findings on the implication of RUFY proteins in the regulation of cytoskeleton and endosome dynamics and their contribution to immunity, cancer and neurodegenerative diseases.

![RUN and FYVE domain containing-proteins in the endo-lysosomal pathway. **(A)** Schematic representation of the RUFY proteins family. **(B)** Description of the endo-lysosomal and autophagy pathways and presumed functional locations of RUFY proteins. Extracellular material is ingested by endocytosis or phagocytosis. The action of different endosomes allows cargo to be sorted, recycled or degraded in a complex and regulated process involving fusion, maturation and transport along the cytoskeleton. Alternatively, during autophagy, obsolete components present in cytosol are captured in autophagosomes prior fusion with lysosomes and degradation (macroautophagy) or directly internalized through endosomal invagination (microautophagy). SE, sorting endosome; EE, early endosome; TGN, trans golgi network; LE, late endosome; MVBs, multi vesicular bodies; RE, recycling endosome, MT, microtubule; CT, centrioles; ER, endoplasmic reticulum. The location of PI3P and RUFY proteins known activity is shown. Created with [BIoRender.com](https://biorender.com/).](fcell-08-00779-g001){#F1}

Endocytosis and Autophagy {#S1.SS1}
-------------------------

Endocytosis and autophagy are membrane traffic pathways required for degradation and recycling of extracellular and intracellular components, respectively ([@B5]). These pathways have a common endpoint at the lysosome, where their cargo is degraded. These both pathways intersect at several stages throughout vesicle formation, transport and fusion and share some of the components of their molecular machineries ([Figure 1B](#F1){ref-type="fig"}).

There are numerous co-existing endocytic pathways, which initiate by the formation of nascent endocytic vesicles formed from plasma membrane invaginations and scissions. These endocytic vesicles undergo homotypic fusion and are rapidly targeted to sorting endosomes (SE). Sorting events initiated in SE determine the fate of internalized cargo molecules, such as recycling to plasma membrane, degradation in lysosomes, or other trafficking events ([@B98]; [Figure 1B](#F1){ref-type="fig"}). On their way to degradation, sorted cargo accumulate in early endosomes (EE), that further mature into late endosomes (LE) through multiple events of cargo and lipid sorting. Late endosomes adopt a membrane organization termed multivesicular bodies, that are enriched in lysobisphosphatidic acid and contain intraluminal vesicles ([@B45]). Next, LE potentiate their hydrolytic competence by fusing with lysosomes ([@B107]) resulting in the degradation of their contents, providing nutrients and key factors to the cell ([@B28]; [@B61]). Notably, endosomes play a role in signal transduction by serving as signaling platforms either for surface activated receptors like Toll-like receptors and epidermal growth factor receptor or metabolic sensors such as mechanistic target of rapamycin complex 1 (mTORC1; [@B2]). Often they promote the degradation of their targets, leading to signal termination ([@B21]). The endocytic pathway has also specialized functions in differentiated cells such as neurotransmitter release and recycling in neurons, or antigen processing and presentation in professional antigen presenting cells, like B cells or dendritic cells ([@B2]; [@B122]; [@B54]). Endocytosis events and endosomes positioning is highly dependent on the dynamic and spatial re-organization of the different cytoskeleton networks that include actin, intermediate filaments, or microtubules ([@B34]; [@B105]).

Complementary to endocytosis, autophagy is an intracellular process by which cells degrade and recycle their own cytoplasmic materials ([@B91]). Autophagy plays a central role in many physiological processes including stress management, development, immunity and aging ([@B110]; [@B165]; [@B33]; [@B93]; [@B29]). Autophagy is partially controlled though mTORC1 activity and is responsible for degradation and recycling of misfolded proteins, as well as obsolete organelles ([@B39]). The endpoint of autophagy is to deliver cytoplasmic material to lysosomes, where like for endocytosed cargo, it is degraded. Several autophagy processes can be distinguished based on the entry mode of the cytosolic components destined for degradation ([Figure 1B](#F1){ref-type="fig"}). Macroautophagy involves engulfment of cytoplasmic contents into a double membrane vesicle termed the autophagosome. The autophagosome fuses then with lysosomes, becoming an autolysosome, in which its cargo is degraded ([@B39]). The presence of specific phosphoinositides lipids, together with Rab GTPases, at a given membrane compartment is often directly correlated with compartment function. One of the common mechanism regulating endocytosis and autophagy is an accumulation of phosphatidylinositol 3-phosphate (PtdIns(3)P) at surface of EE and on intraluminal vesicles of multivesicular endosomes and on autophagosomes ([@B97]; [Figure 1B](#F1){ref-type="fig"}). PtdIns(3)P is also observed at sites of LC3−associated phagocytosis another pathway of internalization used by the cells to ingest large particulate material or microbes. PtdIns(3)P is therefore a beacon used by the cellular machinery to regulate endosomal sorting and autophagy ([@B5]).

RUN Domains {#S1.SS2}
-----------

The presence of a single copy of a RUN and a FYVE domain at their extremities is the key characteristic defining the RUFY family members. RUN domains were named after three proteins bearing similar peptide motifs, [R]{.ul}PIP8, [UN]{.ul}C-14 and [N]{.ul}ESCA (new molecule containing SH3 at the carboxy−terminus) ([@B100]; [@B84]). RUN domains are present in multiple proteins (RUN proteins) in a large panel of organisms ([Figure 2](#F2){ref-type="fig"}) and principally allow direct interactions with small GTPases of the Rap and Rab families ([@B14]; [@B157]). RUN domains adopt a hydrophobic globular structure bearing six conserved blocks named A to F ([Figure 3A](#F3){ref-type="fig"}). These blocks correspond to eight α-helices and some 3~10~-helices. The first helix is crucial to limit hydrophobic exposure and maintain protein solubility of RUN-containing proteins ([@B14]; [@B66]). In spite of strong conservation among the domains present in RUN-containing proteins, the proteins they interact with, their effectors, are highly variable ([@B83]) and the structural features of the RUN domain alone are not sufficient to define binding specificity for one or several members of the GTPase superfamily ([@B38]). Most RUN domain-bearing proteins bind small GTPases, but interactions with other molecules like kinesin 1 have also been described ([@B8]). A direct physical link between RUN proteins with actin filaments and microtubules has been also demonstrated ([@B140]), reinforcing the idea that these molecules are also critical for cellular functions requiring actin remodeling, such as migration or phagocytosis ([@B109]; [@B7]; [@B89]; [@B153]; [Figure 4A](#F4){ref-type="fig"}). Additional functions for RUN domains have been described, for example for the RUN domain present in NESCA, which blocks TRAF6-mediated polyubiquitination of the NF-kappa-B essential modulator and consequently induces NF-kB activation. This is just one of the ways in which RUN proteins can act in signal transduction and the coordination of membrane traffic with actin dynamics upon external stimulation ([@B157]). As well as promoting endosomal fusion through their binding to Rab or Rap GTPases ([@B14]; [@B157]), their interaction with motor proteins, like kinesin or myosin, suggests a role for RUN domains in regulating vesicular and organelle transport ([@B14]; [@B157]). Via these different mechanisms, RUN proteins have been implicated in neuronal development ([@B56]), signaling ([@B131]), migration ([@B157]), and regulation of various cellular function like endocytosis or exocytosis ([@B64]).

![Evolution of RUN and FYVE domain or *rufy* genes among living organisms. Diagram illustrating the evolution of the *rufy* genes. Species representative of various taxonomic groups are listed, data were extracted from the Differential Expression Atlas Genes database (EMBL-EBI). Next to each species studied, the number corresponds to the number of genes having in its sequence a FYVE (green), RUN (blue) or both (red) domain. The "X" corresponds to the appearance of a common *rufy* ancestor gene.](fcell-08-00779-g002){#F2}

![Molecular organization of RUN and FYVE domains from the RUFY proteins family. Alignment of the protein sequences of the RUN **(A)** and FYVE **(B)** domains of the RUFY proteins family in human and mouse. **(A)** RUN consensus blocks are represented by segments **(A--F)**. Rpip8 sequence is used as RUN domain reference, **(B)** FYVE conserved motives and zinc fingers are represented by segments. In the alignment, "x" is any amino acid and "+" represents positively charged amino acid. Eea1 sequence is used as FYVE domain reference. For all alignment, amino acids are colored according to their properties: Cyan for hydrophobic positions (A,V,I,L,M), turquoise for aromatic positions (F,Y,W,H), red for basic residues (K,R), purple for acidic residues (D,E), green for polar uncharged (N,Q,S,T), salmon for cysteine (C), orange for glycine (G) and yellow for proline (P). Gray numbers below alignment means the amino acids position after alignment. Black numbers surrounding the alignments represent the start (left) and end (right) positions of the domains in the peptide sequence of each protein. Alignment were realized with Seaviewer analyzer software ([@B44]). Accession numbers for protein are following: human Rpip8 ([NP_001138297.1](NP_001138297.1)), mouse Rpip8 ([NP_058039.1](NP_058039.1)), human Eea1 ([NP_003557.3](NP_003557.3)), mouse Eea1 ([NP_001001932.1](NP_001001932.1)), human RUFY1 ([NP_079434.3](NP_079434.3)), mouse RUFY1 ([NP_766145.1](NP_766145.1)), human RUFY2 ([NP_060457.4](NP_060457.4)), mouse RUFY2 ([NP_081701.2](NP_081701.2)), human RUFY3 ([NP_055776.1](NP_055776.1)), mouse RUFY3 ([NP_081806.1](NP_081806.1)) human RUFY3XL ([NP_001032519.1](NP_001032519.1)), mouse RUFY3XL ([NP_001276703.1](NP_001276703.1)), human RUFY4 ([NP_940885.2](NP_940885.2)), mouse RUFY4 ([NP_001164112.1](NP_001164112.1)), human FYCO1 ([NP_078789.2](NP_078789.2)), mouse FYCO1 ([NP_001103723.2](NP_001103723.2)).](fcell-08-00779-g003){#F3}

![RUFY proteins are important for intracellular trafficking, signaling and cytoskeleton dynamics. **(A)** Schematic representation of the RUN and FYVE domains activity of RUFY proteins. RUN domains act on signaling, endosomal protein trafficking and cytoskeletal network dynamics via small GTPase proteins. FYVE domains bind PtdIns(3)P and regulates autophagy and endosome trafficking. **(B)** Function of RUFY proteins in homeostatic conditions. **(C)** Consequences of alterations in RUFY proteins functions at the cellular and organismal level.](fcell-08-00779-g004){#F4}

FYVE Domains {#S1.SS3}
------------

FYVE-domain-bearing proteins (for [F]{.ul}ab1, [Y]{.ul}OTB/ZK632.12, [V]{.ul}ac1, and [E]{.ul}EA1) are specifically found in association with membranous organelles enriched in PtdIns(3)P and highly conserved among eukaryotes, including yeast ([@B49]; [Figure 2](#F2){ref-type="fig"}). FYVE domains adopt a zinc finger conformation ([@B90]; [@B70]). In addition to FYVE, ten types of zinc finger folds have been characterized, including conventional, Gal4, GATA-1, TFIIS, MetRS, LIM, RING domain, PKC CRD, and PHD domains. Zinc fingers are structural conformations adopted by peptide chains upon coordination of two Zn^2+^ cations within a cysteine rich region ([@B118]; [@B129]). Unlike most molecules bearing zinc fingers, FYVE proteins display only one copy of the domain located at any position along the peptide chain, highlighting its autonomy as a structural unit. FYVE zinc fingers can stabilize protein-protein or protein-DNA/RNA interactions ([@B31]). A "classical" FYVE domain has eight potential zinc coordinating tandem cysteine positions and is characterized by having basic amino acids around the cysteines. Many members of this family also include two histidine residues in a sequence motif including WxxD, CxxC, R+HHC+xCG and RVC where "x" means any amino acid and "+" a positively charged amino acid ([Figure 3B](#F3){ref-type="fig"}). Most deviations from this sequence can reduce the domain affinity for zinc and destabilize it ([@B129]; [@B90]; [@B128]; [@B70]). Within this structural framework, specific modifications in the non-conserved residues of the domain can radically affect FYVE protein subcellular localization and function, by forming a "turret loop" and a dimerization interface ([@B50]).

With regard to their affinity for PtdIns(3)P, FYVE domain-containing proteins are mostly found associated to EE or phagosomes ([@B129]; [@B41]; [@B128]; [Figure 4A](#F4){ref-type="fig"}). The presence of FYVE domains is therefore correlated to the regulation of membrane traffic, through specific recognition of PtdIns(3)P domains by "R+HHC+xCG" motifs ([@B41]), and modulation by associated phosphatidylinositol kinases. PtdIns(3)P is generated from phosphatidylinositol by Class III PtdIns 3-kinases (PI3K), like Vps34, on target membranes such as nascent autophagosome (omegasomes) ([@B87]), or EE ([@B25]; [@B111]; [@B119]; [Figure 1B](#F1){ref-type="fig"}). In turn, accumulation of PtdIns(3)P recruits and activates effector proteins containing FYVE domains, favoring transport or fusion of target organelles ([@B130]; [@B4]; [@B13]; [@B117]). Affinity for PtdIns(3)P is determined by the pair of histidine residues present in the "R+HHC+XCG" motif of the FYVE domain ([@B124]; [@B27]; [@B73]; [@B51]). This affinity can also be harnessed by FYVE proteins to link endosomes with mRNA, ribonucleoprotein particles (mRNP) and associated ribosomes, playing a role in their long-distance transport in the cell ([@B108]). Importantly, many FYVE proteins homodimerize. Dimerization multiplies the conserved residues displayed by the different signature motifs present in the FYVE domain and contributes to a network of hydrogen bonding and electrostatic interactions that provides positive selection for binding several PtdIns(3)P head groups. PH-dependent insertion of FYVE domain into cell membranes ([@B51]; [@B102]) is reinforced by additional hydrophobic membrane interactions with the turret loop and/or tandem lysine residues. These non-specific interactions promote FYVE domain access to phosphate head groups, that are hindered by the close packing of lipid molecules. This bivalent mechanism increases therefore greatly FYVE domains specificity for PtdIns(3)P-enriched domains and discrimination against other mono- or polyphosphorylated PtdIns species ([@B90]; [@B128]; [@B30]; [@B70]).

FYVE proteins are therefore key players in endocytosis and autophagy and mutations in FYVE domains can alter profoundly these functions, as well as cellular homeostasis ([@B62]). For example, EEA1 protein (early endosome antigen 1) is known to be crucial for endosome dynamics and any mutation in its conserved residues or the oligomerization site can drastically reduce the affinity between its FYVE domain and PtdIns(3)P ([@B129]; [@B40]). In this context, RUFYs proteins, by bearing a N-terminal RUN domain, one or several copies of a coiled-coil domain next to a C-terminal FYVE domain ([Figure 1A](#F1){ref-type="fig"}) have all the features required to carry-out specific adaptor functions to regulate endocytosis or autophagy by impacting on organelle fusion and mobility along the cytoskeleton.

The RUFY Proteins Family {#S1.SS4}
------------------------

The RUFY family encompass four genes named *rufy1* to *4*, sharing homologies and displaying specific tissue expression and alternative splicing. *Rufy* genes are relatively conserved genes, absent from prokaryotes and fungi. Upon evolution, the emergence of the common ancestor appeared in vertebrates and arthropods, which possess one ortholog (*CG31064*) ([Figure 2](#F2){ref-type="fig"}). No RUFY protein could be detected In *Caenorhabditis elegans* and only a FYVE-bearing protein (*T10G3.5)* considered as an ortholog of human EEA1 shows some sequence similarities with the RUFY family. *T10G3.5* exhibits PtdIns(3)P binding activity and is involved in endocytosis, being mostly expressed in epidermis and intestine of *C. elegans* ([@B49]). In chordates, Rubicon (RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein) and FYVE And Coiled-Coil Domain Autophagy Adaptor 1 (FYCO1), display structural and functional features, potentially categorizing them as RUFY proteins. Rubicon was identified as a component of the Class III PI3K complex and a negative regulator of autophagy and endosomal trafficking ([@B85]; [@B164]). Like RUFYs, Rubicon contains multiple functional domains that interact with other proteins, including a RUN, a CC and a FYVE-like domains ([@B149]). However, despite these similarities, the poor degree of sequence homology and the lack of conservation of its FYVE-like domain, which was found not to bind to PI(3)P ([@B13]), prevented Rubicon's integration within the RUFY proteins family, conversely to FYCO1, which we propose here to name RUFY5 and detail the characteristics below.

RUFY1 {#S2}
=====

RUFY1, previously named Rabip4 is an 80 kDa protein, mainly expressed in the brain, kidney, lung, placenta and testis. There are two RUFY1 isoforms Rabip4, and Rabip4' that has an additional 108 amino acid upstream of the N-terminal RUN domain ([Figure 1A](#F1){ref-type="fig"}). They were both shown to interact with the small endosomal GTPases Rab4, Rab5, and Rab14 ([@B35]; [@B144]; [Table 1](#T1){ref-type="table"}). RUFY1 inactivation inhibits efficient recycling of endocytosed transferrin, implicating RUFY1 in the regulation of EE functions through cooperative interactions with Rab4 and Rab14 ([@B22]; [@B155]; [@B96]). This was further demonstrated by the alteration of epidermal growth factor receptor endocytic trafficking kinetics in cells depleted of RUFY1 ([@B43]) and the hijacking of RUFY1 by the bacteria *P. gingivalis* to escape lysosomal degradation ([@B134]). In melanocytes, RUFY1 was found to form a complex with rabenosyn-5, KIF3A-B, Rab4A and adaptor protein-3 (AP-3) to differentially regulate tyrosinase-related protein-1 and tyrosinase sorting in endosomes, contributing to melanosome maturation ([@B96]; [Table 1](#T1){ref-type="table"}). Moreover, silencing the Rabip4' isoform of RUFY1 was shown to promote outgrowth of plasma membrane protrusions, and to regulate the spatial distribution of lysosomes at their tips, through an interaction with AP-3 ([@B58]; [Figures 1B](#F1){ref-type="fig"}, [4B](#F4){ref-type="fig"}). RUFY1 is also capable of controlling cell migration by regulating integrin trafficking ([@B144]), presumably via endocytosis. In full agreement with a role of RUFY1 in regulating endosomal dynamics, a single nucleotide polymorphism (S705A) in the *rufy1* gene was associated with high blood glucose levels and type 2 diabetes mellitus susceptibility in an exome-wide association study (EWAS; [@B154]). This result is consistent with the early finding that Rabip4 expression leads to Glucose transporter-1 (Glut-1) intracellular retention ([@B22]). Interestingly RUFY1 display a SH3-binding motif "PxxPxP" embedded in the FYVE domain and is able to interacting with the epithelial and endothelial tyrosine kinase (ETK), and possibly regulates endocytosis through this interaction ([@B156]). Another EWAS, aiming to find early-onset Alzheimer's Disease (AD) susceptibility genes, identified RUFY1 among genes involved in endo-lysosomal transport and known to be important for the development of AD ([@B69]; [Figure 4C](#F4){ref-type="fig"}).

###### 

Summary of RUFY proteins functional interactions.

  Protein (Aliases)                                 Binding partner                           Functions                                                                                                                               Study
  ------------------------------------------------- ----------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------- --------------------------
  **RUFY1** (Rabip4; Rabip4'; ZFYVE12)              Rab4                                      Recycling endosomal trafficking                                                                                                         [@B22]
                                                    Etk                                       Regulation of endocytosis through its interaction with RUFY1                                                                            [@B156]
                                                    Rab14                                     RUFY1's recruitment, endosome tethering and fusion                                                                                      [@B155]
                                                    AP-3                                      Regulates spatial distribution of lysosome                                                                                              [@B58]
                                                    Rabenosyn-5/KIF3A- B/Rab4A/AP-3 complex   Sorting endosome pathway in endosomal membrane in melanocytes and segregates tyrosinase-related protein-1                               [@B96]
                                                    PODXL1                                    Increases cell proliferation, migration and invasion                                                                                    [@B163]
  **RUFY2** (LZ-FYVE; Rabip4r; KIAA1537; FYVE13)    Rab33A/Rab4A/Rab6A                        Endosome dynamic, Golgi complex-associated Rab33 and autophagosome formation on omegasomes                                              [@B38]; [@B64]
                                                    RET                                       Lead to a fusion of the RET tyrosine kinase domain to a RUN domain and a coiled-coil domain appear to be critical for tumorigenesis     [@B126]
  **RUFY3** (Singar-1; RIPX; ZFYVE30; KIAA087)      Rap2                                      Control neuronal polarity                                                                                                               [@B59]
                                                    Fascin                                    Control the growth of axons and neuronal growth cone                                                                                    [@B148]
                                                    Rab5/Rab33A                               Acts on endosomal trafficking                                                                                                           [@B158]; [@B38]
                                                    GPM6a-Rap2-STEF/Yial2 complex             Facilitates cell polarity                                                                                                               [@B55]
                                                    PAK1                                      Induce cell migration and invasion in gastric cancer                                                                                    [@B145]
                                                    FOXK1                                     Increases cells migration RUFY3-mediated with metastasis invasion in colorectal cancer                                                  [@B151]
                                                    HOXD9                                     HOXD9 transactivate RUFY3 and it overexpression induce gastric cancer progression, proliferation and lung metastasis                    [@B166]
  **RUFY4** (ZFYVE31)                               Rab7                                      Autophagosome formation and lysosome clustering                                                                                         [@B138]
  **FYCO1/RUFY5** (ZFYVE7; RUFY3; CTRCT18; CATC2)   MAP1LC3A/B                                Autophagosome formation and elongation                                                                                                  [@B20]; [@B101]
                                                    Rab7                                      Endosomal transport by acting with microtubule plus end-direction transport                                                             [@B147]
                                                    Kinesin-1                                 Allows translocation from the late endosome, lysosome and autophagosome to the plasma membrane through plus-end microtubule transport   [@B65]; [@B113], [@B112]

RUFY2 {#S3}
=====

RUFY2 (or Leucine zipper FYVE-finger protein, LZ-FYVE) is a 75 kDa protein originally identified as an activating transcription factor-2 interactor embryogenesis ([@B31]), preferentially located in the nucleus and expressed during. After development, RUFY2 expression remains high in the brain, lung, liver and the gastrointestinal tract ([@B156]). RUFY2 displays two N-terminal leucine zipper domains as well as a C-terminal FYVE-finger domain. Although it is likely to have a nuclear function at early stages of embryonic development, the presence of a FYVE domain suggests a cytoplasmic role for RUFY2 in regulating membrane traffic in fully differentiated cells. Importantly, the RUN domain of RUFY2 was shown to associate specifically with the Golgi complex-associated Rab33A ([@B38]; [Table 1](#T1){ref-type="table"}). Given the reported interaction of Rab33A and Rab33B with Atg16L and its putative role in regulating autophagy ([@B37]), RUFY2 could contribute to autophagosome formation through a dual interaction with Rab33A and PtdIns(3)P on omegasomes ([Figures 1B](#F1){ref-type="fig"}, [4B](#F4){ref-type="fig"}). Irrespective of its function, *rufy2* expression is subject to modulation by the micro RNA miR-155 ([@B6]), which is an important regulator of immune cells development and inflammatory responses ([@B15]). The *rufy2* gene is also frequently found mutated in cancer cells, with the most frequent mutations converting it into a strong target for nonsense mediated mRNA decay, thereby decreasing considerably its expression ([@B120]; [Figure 4C](#F4){ref-type="fig"}).

RUFY3 {#S4}
=====

RUFY3, also known as Rap2-interacting protein X (RIPX) ([@B66]) or Single Axon-Related 1 (Singar1) ([@B94]), is the best characterized member of the RUFY family. RUFY3, the smallest of the RUFY proteins with a molecular weight of 53 kDa ([Figure 1A](#F1){ref-type="fig"}), is mostly expressed in neurons ([@B64]). Neuronal RUFY3 is atypical, since it lacks a FYVE domain and is considered as part of the RUFY family based on strong sequence similarities with the other members, notably in the RUN and coiled-coil domains ([Figure 2A](#F2){ref-type="fig"}). RUFY3 is distributed between the cytosol and at the plasma membrane, but not in intracellular vesicles, presumably because it lacks a FYVE domain. In artificial conditions, like following expression of the dominant gain of function mutant form of Rab5 (Q79L) in U937 cells, RUFY3 was found associated in large vesicle structures and to co-immunoprecipitate with Rab5, via an interaction with its carboxyl terminal domain and surprisingly not its RUN domain ([@B158]). Like RUFY2, RUFY3 was also shown in a 2-hybrid screen and by co-immunoprecipitation to bind Rab33, through its coiled-coil domain 1 (CC1; [@B38]). In 293T and 3Y1 cell lines however, RUFY3 was shown not to interact with several small GTPases, including Rab2, Rab5, Rab7, Rho, and Ras. This suggests that either RUFY3 requires cell specific partner proteins or post-translation modifications to be able to bind to small GTPases. RUFY3 was first described as interacting with Rap2, a small Ras-like GTPase, via a 173 residue fragment (83--255) located in the RUN domain ([@B59]; [@B66]; [Table 1](#T1){ref-type="table"}). Together with Rap1, Rap2 interacts with Ras effectors, such as Raf, PI3K, and Ral guanine nucleotide dissociation stimulator, inhibiting activation of their downstream targets, and thus suppressing Ras oncogenic activity ([@B66]; [@B99]). In the adult nervous system, Rap1 and Rap2 also regulate the maturation and plasticity of dendritic spine and synapses. By forming a complex together with Rap2 and Fascin, RUFY3 interacts with the filamentous actin network and controls the growth of axons and neuronal growth cone ([@B148]; [Table 1](#T1){ref-type="table"}). Recent mechanistic studies indicate that RUFY3 accumulates in lipid rafts by forming a Glycoprotein M6A (GPM6a)-RUFY3-Rap2-STEF/Yial2 complex ([@B55]; [Table 1](#T1){ref-type="table"}). This complex activates the Rac guanine nucleotide exchange factor ([@B56]), impacting actin organization and promoting neuronal polarity and growth ([Figure 4B](#F4){ref-type="fig"}). RUFY3 seems therefore to have different axogenic functions in brain ([@B94]; [@B56]) and not surprisingly, roles for RUFY3 in amyotrophic lateral sclerosis ([@B3]), major depressive disorder ([@B1]) and AD ([@B160]) have been reported. Olfactory dysfunction occurs in 90% of AD cases and is correlated with elevated *rufy3* expression in glomerular and mitral layers of the olfactory bulb ([@B160]). RUFY3 is cleaved by caspase 3 and critically required for caspase-mediated degeneration of tropomyosin receptor kinase A positive sensory axons *in vitro* and *in vivo* ([@B53]; [Figure 4C](#F4){ref-type="fig"}). Removal of neuronally enriched RUFY3 is able to block caspase 3-dependent apoptosis, while dephosphorylation of RUFY3 at residue S34 appears required for its degradation ([@B53]). Analysis of *rufy3*-deficient mice supports a second distinct function for RUFY3 in neuronal growth and polarity, since mutant embryos show defects in axonal projection patterns. These occur in addition to the prevention of CASP3-dependent apoptosis in dorsal root ganglions. RUFY3 appears therefore to be key for nervous system development, remodeling and function, explaining the embryonic lethality displayed upon *rufy3* genetic inactivation in mouse ([@B53]).

With the current advance in genomics and single cell RNA sequencing, specific gene expression patterns can be revised and more accurately defined. Analysis of several genomic databases (BioGPS, NCBI, Human Atlas Protein, ImmGen, Ensembl) reveal that, in addition to neurons, RUFY3 expression can be detected in other tissues and cell types. Moreover, the *rufy3* gene appears to have many transcriptional variants, leading to the expression of different protein isoforms. Two of these isoforms display a C-terminal region extended by 150 amino acids, compared to the previously identified neuronal isoform of RUFY3. Importantly, these previously uncharacterized longer isoforms (RUFY3XL) possess the same RUN domain and a putative FYVE domain in their C-terminus ([Figure 1A](#F1){ref-type="fig"}), indicating that RUFY3 is a legitimate member of the RUFY family. In contrast to classic FYVE zinc fingers, genomic databases reveal this putative FYVE domain appears to lack the tandem histidine residue cluster that defines affinity for PtdIns(3)P ([Figure 3B](#F3){ref-type="fig"}). Interestingly, the SH3 binding site embedded in the RUFY1 and RUFY2 FYVE domains is also present in RUFY3XL, suggesting a potential signal transduction activity for this uncharacterized isoform. The translation of *rufy3xl* mRNA into a functional protein and its capacity to bind PtdIns(3)P remain to be demonstrated. If true, a role for RUFY3 in the coordination of endosome dynamics or organelle transport could be hypothesized. This idea is supported by the observation that RUFY3 is present in Staufen2-containing messenger ribonucleoprotein particles, that are used to transport mRNAs along neuronal dendrites to their site of translation ([@B81]). FYVE proteins have already been implicated in endosome-mediated transport of mRNP ([@B108]) and RUFY3XL could therefore also perform this function. The existence of FYVE domain bearing isoforms, might extend and diversify its function in other specialized cells.

RUFY4 {#S5}
=====

RUFY4 is a 64 kDa that is atypical among the RUFY family members, since it bears several non-conserved residues in its RUN domain and it lacks the tandem histidine cluster and the SH3 binding domain normally present in the FYVE domain ([Figures 1A](#F1){ref-type="fig"}, [3A,B](#F3){ref-type="fig"}). RUFY4 was shown to interact with PtdIns(3)P enriched membranes ([@B138], [@B137]). Interestingly, EMBL-EBI and SMART genomic databases show that *rufy4* is present only in mammals, suggesting that *rufy4* is the most recently evolved gene in the RUFY family ([Figure 2](#F2){ref-type="fig"}). RUFY4 levels are extremely low in most cells and tissues with the exception of lungs and lymphoid organs. RUFY4 was found to be strongly induced *in vitro* in dendritic cells differentiated from bone marrow progenitors in presence of GM-CSF and IL-4. *In vivo*, its expression was confirmed in alveolar macrophages and in lung dendritic cells isolated from asthmatic mice ([@B138]). RUFY4 interacts with Rab7 through its RUN domain and promotes the generation of large autophagosomes ([@B138]; [Figure 4B](#F4){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). RUFY4 over-expression induces the degradation of the autophagy effector LC3/ATG8 and triggers clustering of LAMP1-positive late endosomal compartments. These compartments are distinct from large abnormal autophagosome-like structures positive for RUFY4 and Syntaxin-17, a Qa SNARE involved in autophagosome formation and fusion ([Figure 4C](#F4){ref-type="fig"}). RUFY4 was also proposed to interact with PLEKHM1 and the HOPS complex, which are implicated in LE and lysosome dynamics and positioning ([@B137]). RUFY4 seems therefore able to harness the classical autophagy machinery to facilitate autophagosome formation and increase autophagy flux by acting at different biochemical steps ([@B138]). By optimizing effector protein activity and organelle distribution, RUFY4 expression facilitates the elimination of both damaged mitochondria and intracellular bacteria in phagocytes. RUFY4 expression in HeLa cells can prevent replication of *Brucella abortus* ([@B138]) and *Salmonella typhimurium* ([@B72]) suggesting that RUFY4 has a key role in anti-bacterial responses in the lung. It also potentially acts to drive immunity though the regulation of endocytosis and autophagy, necessary for the presentation at the cell surface of antigens from intracellular pathogens ([@B138]).

FYCO1 {#S6}
=====

FYCO1 is a 150 kDa protein bearing a RUN and a FYVE domains. In several databases, *fyco1* was misidentified as *rufy3*, although these two genes are present on completely distinct chromosomes, in human chromosome 3 and 4, respectively. At the sequence level, although it is larger, FYCO1 appears to be a RUFY4 ortholog gene ([Figures 3A,B](#F3){ref-type="fig"}), suggesting that FYCO1 belongs to the RUFY family. We therefore propose that it could be annotated as RUFY5 to fit the family nomenclature. Separating its N-terminal RUN domain from the FYVE zinc finger, FYCO1 has several CC domains, as well as a LC3/ATG8 Interacting Region (LIR) and a Golgi Dynamic (GOLD) domain in its C-terminus ([Figure 1A](#F1){ref-type="fig"}). FYCO1 preferentially interacts with MAP1LC3A/B of the Atg8-familly proteins through its LIR ([@B101]; [@B20]). Coiled-coil domains promote FYCO1 dimerization and have been shown to mediate the formation of a complex with Rab7, via a part of the CC located upstream of the FYVE domain ([@B102]; [@B147]; [Table 1](#T1){ref-type="table"}). Overexpression of FYCO1 was shown to redistribute LC3- and Rab7-positive structures to the cell periphery in a microtubule-dependent manner ([@B102]). This effect is mediated by the central part of the CC region and suggests a role for FYCO1 in the transport of autophagic vesicles ([Figure 4B](#F4){ref-type="fig"}). The capacity of FYCO1 to interact with Rab7 and LC3A/B on the external surface of autophagosomes, and PtdIns3P enriched membranes through its FYVE domain, is likely to be key to its function as an adaptor protein. Indeed, these interactions allow microtubule plus end-directed transport and protrusion of endocytic organelles, including autophagosomes ([@B103]), LE ([@B112], [@B113]), lysosomes ([@B95]; [@B57]; [@B75]), and phagosomes ([@B79]). Endoplasmic reticulum (ER) and endosomes are connected through contact sites, the numbers of which increase as endosomes mature. The functions of such sites include to control the association of endosomes with the minus-end-directed microtubule motor dynein and to mediate endosome fission. Repeated LE--ER contacts promote microtubule-dependent translocation of LEs to the cell periphery and subsequent fusion with the plasma membrane ([@B113]). Such fusion induces outgrowth of protrusions and neurites in the neuroendocrine cell line PC12, which require the ER-associated protein protrudin on the ER and FYCO1 to interact with LEs and kinesin 1 ([@B65]; [Table 1](#T1){ref-type="table"}). FYCO1 has been described as a novel mediators of invalopodia formation and function of Protrudin-mediated ER--endosome contact sites ([@B104]). Multiple studies highlight the critical function of FYCO1 in autophagy and autophagosome/endosome trafficking ([@B26]) with pathological consequences arising when FYCO1 function is altered ([Figures 4B,C](#F4){ref-type="fig"}). Mutations in the *fyco1* gene affect autophagy and cause autosomal-recessive congenital cataracts by altering lens development and transparency in patients ([@B17], [@B18]; [@B9]; [@B23]; [@B16]; [@B36]; [@B63]; [@B46]; [@B74]). Sequencing studies of candidate genes potentially involved in several neuromuscular or neurodegenerative diseases have identified rare variants of autophagy related proteins like VCP and SQSTM1. Among these genes, a missense *fyco1* variant was identified to cause sporadic inclusion body myositis ([@B47]; [@B115]; [@B10]; [Figure 4C](#F4){ref-type="fig"}). Finally FYCO1 has been implicated in the autophagic clearance of specialized particles or aggregates, like male germ cell-specific RNP ribonucleoprotein granules ([@B24]), post-mitotic bodies ([@B26]) or α-synuclein aggregates ([@B116]).

RUFY Proteins and Cancer {#S6.SS1}
------------------------

As describe above, RUFY proteins play a central role in cellular functions by regulating vesicular trafficking and its interactions with the cytoskeleton. Neuronal deficit and neurodegeneration are the most obvious manifestations of RUFY proteins alteration. Not surprisingly, however, given their relatively broad adaptors functions, RUFY proteins have taken center stage in the oncology field.

The ETK tyrosine kinase has been shown to play a pivotal role in a variety of cellular processes including proliferation, differentiation, motility, and apoptosis ([@B156]; [@B68]; [@B167]; [@B146]). Tyrosine phosphorylation of RUFY1 by ETK appears to be important for its endosomal localization and could play an important role promoting tumoral transformation by affecting downstream effectors of PI3-kinase. RUFY1 was also shown to interact with podocalyxin-like protein (PODXL), a transmembrane glycoprotein with anti-adhesive properties associated with poor prognosis of several cancers ([@B135]; [@B52]; [Table 1](#T1){ref-type="table"}). Gastric cancer progression is significantly increased upon PODXL expression, a phenotype reduced by concomitant RUFY1 silencing. Depletion of RUFY1 inactivates the PI3K/AKT, NF-κB and MAPK/ERK signaling pathways and reduces drastically migration and invasion of cancer cells *in vitro* ([@B163]). Given the positive correlation between *podxl* and *rufy1* expression in tissues and serum, *rufy1* was proposed as a potential biomarker for gastric cancers stratification ([@B163]; [Figure 3C](#F3){ref-type="fig"}). Like RUFY1, a role for RUFY2 in various cancer has been reported ([@B120]; [@B162]; [@B126]). *Rufy2* is one of the most frequently mutated genes in high-microsatellite instability tumors and colorectal cancer ([@B120]). Gene rearrangement of the proto-oncogene *ret* with *rufy2* have been shown to drive tumorigenesis in lung adenocarcinoma ([@B162]) and papillary thyroid carcinoma ([@B126]). The gene rearrangement leads to a fusion of the RET tyrosine kinase domain with RUFY2 RUN domain and coiled-coil domain; this appears to be critical for tumorigenesis ([@B126]; [Table 1](#T1){ref-type="table"}). *Rufy2* mRNA is the target of several microRNAs, including miR-146a, miR-196a-5p and miR-155 ([@B6]). Dysregulated microRNA targeting of RUFY2 expression was found important for the development of human glioblastoma and ovarian cancer, suggesting a tumor suppression role for RUFY2 ([@B77]; [@B161]; [Figure 4C](#F4){ref-type="fig"}). Given the key role of RUFY3 in cell migration, membrane transport, and cellular signaling, through its interaction with rap2, it is not surprising that RUFY3 dysregulation has been implicated in several cancer processes and metastatic tumor spread. The abnormal expression of RUFY3 is linked to poor prognosis. It can promote growth, invasion and metastasis in lung adenocarcinoma, gastric cancer cells or colorectal cancer ([@B151], [@B152]; [@B88]; [@B166]). RUFY3 overexpression and its interaction with P21-activated kinase-1 (PAK1) leads to the formation of F-actin-enriched protrusive structures, increased epithelial-mesenchymal transition and gastric cancer cell migration ([@B67]; [@B141]). Several transcription factors, including Forkhead box k1 (FOXK1) and Homebox D9 (HOXD9) involved in cancer progression ([@B92]; [@B132]; [@B78]; [@B106]; [@B150]; [@B76]; [@B166]), have been shown to regulate RUFY3 expression and activity ([@B151]; [@B166]; [Table 1](#T1){ref-type="table"}). So far, no correlation has been found between RUFY4 and any type of cancer. FYCO1 has also been implicated in colorectal cancer progression ([@B121]) and recent studies have concluded that FYCO1 may serve as a biomarker in bladder cancer ([@B32]) or hepatocellular carcinoma ([@B143]; [Figure 4C](#F4){ref-type="fig"}). Plus, FYCO1 can indirectly associated with cell invasion ([@B104]).

Conclusion {#S7}
==========

Although they have been poorly characterized to date, RUFY proteins play a central role in cellular homeostasis by regulating endocytosis, autophagy and coordinating organelle transport with signal transduction cascades. It is important to note that RUFY proteins also provide a regulatory link between cytoskeletal dynamics and membrane trafficking. Consequently, these proteins have adaptive functions by acting on localized actions (through PtdIns(3)P) and signaling (through small GTPases), which can affect key biological functions in specialized cells, such as migration, tissue repair or targeted secretion. The dysregulated expression of RUFY proteins has therefore severe consequences on cell differentiation and polarization, causing cancers or neurodegenerative diseases. However, further molecular and physiological analyses will be required to understand how these proteins exert their functions in specialized cell types like immune cells or neurons. Immunocytes require endocytosis and migration to perform their functions within primary and secondary lymphoid organs or at sites of infection. The restricted expression of RUFY4, as well as the existence of splicing variants of RUFY3 in alveolar macrophages and dendritic cells, suggest a role for these molecules in phagocytes. Of importance will be the characterization of the different molecules interacting either with their RUN or FYVE domains in a cell specific manner. Identification of these RUFY's interactors will be crucial to establish the functionality of the domains and their importance for signaling on one end and subcellular targeting at the other end. The coiled-coil structural domains found in the central part of the RUFY proteins should also be scrutinized. CC domains, in addition to support homodimerization and increase affinity for PtdIns(3)P, could also be determinant in promoting RUFY proteins interactions with effector molecules, like Rab7, as observed for FYCO1. The nature and pattern of expression of these effector molecules will allow to sort the different activities displayed by the RUFYs in individual cell types and thereby shed light on their physiological importance in health and diseases.
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